For research use only. Not for therapeutic Use.
Solanezumab is a humanized monoclonal IgG1 antibody directed against the mid-domain of the amyloid-β (Aβ) peptide. Solanezumab has the potential for the research of Alzheimer’s disease[1].
| Catalog Number | I042404 |
| CAS Number | 955085-14-0 |
| Purity | ≥95% |
| Reference | [1]. [1]Honig LS, et al. Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease. N Engl J Med. 2018 Jan 25;378(4):321-330. |
